---
schema_version: "secwatch.filing_event.v1"
accession: "0001062822-21-000055"
form_type: "8-K"
ticker: "LXRX"
cik: "0001062822"
company_name: "LEXICON PHARMACEUTICALS, INC."
filed_at: "2021-09-09T23:59:59+00:00"
generated_at: "2026-06-29T04:43:25.555716+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Lexicon appoints Jeffrey L. Wade as President, effective Oct 1, 2021; salary increased to $505k

## Summary
- Jeffrey L. Wade, current EVP/CFO, promoted to President effective Oct 1, 2021; reports to CEO Lonnel Coats.
- Base salary raised from $475,134 to $505,000; bonus target increased from 40% to 50% of base.
- Wade has been with Lexicon since 1999, previously a partner at Andrews & Kurth L.L.P.

## SEC filing metadata
- accession: 0001062822-21-000055
- form_type: 8-K
- ticker: LXRX
- cik: 0001062822
- company_name: LEXICON PHARMACEUTICALS, INC.
- filed_at: 2021-09-09T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1062822/000106282221000055/0001062822-21-000055-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1062822/000106282221000055/lxrx-20210903.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001062822-21-000055
- JSON: https://secwatch.observer/filing/0001062822-21-000055.json
- Plain text: https://secwatch.observer/filing/0001062822-21-000055.txt

## Key facts
- Executive change
  Jeffrey L. Wade was appointed as President at LEXICON PHARMACEUTICALS, INC..
  - Action: appointed
  - Role: President
  source text: On September 3, 2021, in preparation for the potential commercial launch of sotagliflozin, if approved, and management of future growth of our company, our board of directors appointed Jeffrey L. Wade as president, effective October 1, 2021, continuing to report to Lonnel Coats, who remains our chief executive officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1062822/000106282221000055/0001062822-21-000055-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.